Make “Buy & Build” understandable
Your Contact Michael Diegelmann +49 611 20 58 55 18diegelmann@cometis.de Buy & Build strategists face major communication challenges. It is well known that many takeovers fail. “Megadeals” in particular, such as Daimler/Chrysler and most recently Bayer/Monsanto, often fail to achieve their ambitious goals. Accordingly, the public is critical of many company acquisitions. There is […]
The “downfall of equity research” … opens up new opportunities for listed SMEs
Your Contact Michael Diegelmann +49 611 20 58 55 18diegelmann@cometis.de Research reports are becoming rarer. The current legal requirements of the EU Directive MiFID II are further strengthening the trend. In particular, small and medium-sized stock corporations are disappearing from the cover lists of research departments. Their securities are traded less frequently and the […]
July 29, 2019 | Dermapharm Holding SE: Dr. Jürgen Ott named new CMO
Grünwald, July 29, 2019 – The Supervisory Board of Dermapharm Holding SE (“Dermapharm”) has announced a change in the composition of the Management Board. The current Chief Marketing Officer Stefan Grieving will be leaving the company for health reasons on July 31, 2019. Dr. Jürgen Ott to succeed him as of October 1, 2019.
July 29, 2019 | KPS with robust sales growth in the 3rd quarter 2018/2019
Corporate news to the archive KPS with robust sales growth in the 3rd quarter 2018/2019 Sales significantly increased by 6.9 % to 44.8 million euros Revenues 4.4 % up on 2017/2018 in a 9-month comparison EBITDA increased by 23.8 % in comparison with the first nine months of 2017/2018 Lucrative projects acquired and customer […]
Cannabis companies are welcome
Your Contact Michael Diegelmann +49 611 20 58 55 18diegelmann@cometis.de The recent non deal roadshow organized by cometis for a Canadian cannabis company has met with great interest from many investors. In just three days, the Canadian board was able to meet 29 European investors. In addition to 12 one-on-ones, 17 investors made use of […]
July 18, 2019 | zooplus AG: Sales grow 14% to EUR 363 m in the second quarter of 2019
Corporate news to the archive zooplus AG: Sales grow 14% to EUR 363 m in the second quarter of 2019 Sales growth rate rises to 14% in the second quarter of 2019 from 13% in the first quarter (year-on-year comparison) Sales increase for the first half year by EUR 84 m to EUR 727 m […]
Halfhearted bill of the Minister of Justice
Your Contact Michael Diegelmann +49 611 20 58 55 18diegelmann@cometis.de Michael Diegelmann, Member of the Management Board of cometis AG, explains in the Euro am Sonntag of 7 July 2019: “The EU wants to strengthen shareholders’ rights. The corresponding directive must now be transposed into national law. And there is a huge problem in this […]
04 July 2019 | DEAG: Convertible bond 2016/2019 fully converted into shares
Berlin, 4 July 2019 – DEAG Deutsche Entertainment Aktiengesellschaft (DEAG), Berlin, (ISIN: DE000A0Z23G6 | Ticker Symbol: ERMK), has announced that all convertible bonds (ISIN DE000A2AAX86) with a total par value of EUR 4,300,000.00 have been converted into new no-par value ordinary bearer shares of DEAG (the “shares”). This equates to 1,228,553 shares on the basis of the conversion ratio defined in the bond terms. In today’s mandatory conversion, an additional 571,420 shares were generated, resulting in a new total of 19,625,976 shares.
04. Juli 2019 | creditshelf on strong growth path
Frankfurt am Main, Germany, 04 July 2019 – creditshelf Aktiengesellschaft, a pioneer in digital SME financing in Germany, managed to more than double its arranged loan volume in the first half 2019 compared with the same period of the previous year. The positive development of its loan business in the first half 2019 is reflected in the following numbers:
Michael Diegelmann in BörseOnline from June 27, 2019: “Employee representatives should work in the supervisory boards towards more investments”.
Your Contact Michael Diegelmann +49 611 20 58 55 18diegelmann@cometis.de Michael Diegelmann (CEO cometis): “There is too little investment in Germany. This applies not only to government infrastructure spending but also to many companies. This is astonishing, because at around 600 companies with equal co-determination, employee representatives occupied half of the seats on the supervisory […]